Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose in Idaho
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Idaho Pricing in Context
In Idaho, CPT code 0052A (Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose) carries an average Medicare payment of $42.03 — 4% above the national benchmark of $40.50. 13 providers across the state submitted claims for this procedure in 2023, performing 41 total services. Individual payments in ID ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Idaho is $92.93, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Idaho sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Vaccines & Injections procedures, the estimated commercial insurance price in Idaho lands near $88.26, with self-pay cash prices typically around $57.07. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose cost in Idaho?
The average Medicare payment for Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose in Idaho is $42.03, which is 4% above the national average of $40.50. Providers in ID typically bill $92.93 for this procedure.
What does Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose cost with insurance in Idaho?
With commercial insurance in Idaho, Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose costs an estimated $88.26. Without insurance, the estimated cash price is $57.07. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose in Idaho?
13 providers in Idaho billed Medicare for Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose in 2023, performing 41 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose cheaper in Idaho than the national average?
No — Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Second Dose costs 4% above the national average in Idaho. The state average Medicare payment is $42.03 compared to $40.50 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.